Gene · 113451
Papers1,387
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,387
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Single-cell atlas reveals a pro-metastatic RELB+ neutrophil-myeloid subset underlying lymph node metastasis in EGFR-wildtype LUAD. | Front Cell Dev Biol | 2026 | 41783590 | PubTator, text mining | PubMed |
| Antibody-drug conjugates in colorectal cancer: advances in targeted delivery and personalized oncology. | Front Bioeng Biotechnol | 2026 | 41768137 | PubTator, text mining | PubMed |
| A Critical Analysis of the Impact of Etoposide as a Topoisomerase II Inhibitor in Cervical Cancer Treatment: A Review. | Cancer Med | 2026 | 41766523 | PubTator, text mining | PubMed |
| Transformer-Based Deep Learning Model Using MRI-Derived Microvascular Atlas for Predicting Lymphovascular Invasion in Breast Cancer Patients. | Technol Cancer Res Treat | 2026 | 41761479 | PubTator, text mining | PubMed |
| MRI differentiation of usual type endocervical adenocarcinoma and cervical squamous cell carcinoma. | PLoS One | 2026 | 41758898 | PubTator, text mining | PubMed |
| Molecular mechanisms and therapies for tumor inhibition through the arginine metabolism pathway. | Front Oncol | 2026 | 41756322 | PubTator, text mining | PubMed |
| Developing an interpretable clinical-radiomics machine learning model using whole transition zone MRI analysis for improving diagnosis of transition zone prostate cancer. | Front Oncol | 2026 | 41756314 | PubTator, text mining | PubMed |
| A Joint Parallel Timing Recovery Loop with Low Complexity for Terahertz Communication System and Its FPGA Implementation. | Sensors (Basel) | 2026 | 41755104 | PubTator, text mining | PubMed |
| Enhanced Payload Release Enables Disitamab Vedotin to Surpass Trastuzumab Emtansine and Retain Efficacy in Acquired Resistance to Clinical Anti-HER2 Therapies. | Pharmaceutics | 2026 | 41754950 | PubTator, text mining | PubMed |
| Frontiers in Antibody-Drug Conjugates: Mechanisms, Design Innovations, and Clinical Applications in Targeted Cancer Therapy. | Pharmaceuticals (Basel) | 2026 | 41754865 | PubTator, text mining | PubMed |
| 2025 FDA TIDES (Peptides and Oligonucleotides) Harvest. | Pharmaceuticals (Basel) | 2026 | 41754785 | PubTator, text mining | PubMed |
| The Diet-Microbiota-Polyamine Axis in Intestinal Aging: Microbial Pathways, Functional Foods, and Physiological Implications. | Nutrients | 2026 | 41754095 | PubTator, text mining | PubMed |
| HER2-Low Breast Cancer: Biological Framework and Determinants of HER2 Instability. | Medicina (Kaunas) | 2026 | 41752702 | PubTator, text mining | PubMed |
| A Systematic Review of Major Advances in Breast Cancer Therapeutics in 2025: Synthesis of Conference and Published Evidence. | Int J Mol Sci | 2026 | 41752108 | PubTator, text mining | PubMed |
| Improving the SSIR Method: Implementation of an Exhaustive Multilevel Scan for Categorical Variables. | Int J Mol Sci | 2026 | 41752107 | PubTator, text mining | PubMed |
| The Impact of HER3 Dynamics Altered by HER3-DXd Alone and in Combination with Driver Oncogene Inhibitors on HER3-DXd Efficacy. | Int J Mol Sci | 2026 | 41752065 | PubTator, text mining | PubMed |
| Major Advances in Gynecologic Oncology in 2025: Systematic Review and Synthesis of Conference and Published Evidence. | Biomedicines | 2026 | 41751194 | PubTator, text mining | PubMed |
| Exploring the Role of Advanced MRI in Understanding Glioblastoma Biology: A Scoping Review. | Cancers (Basel) | 2026 | 41749898 | PubTator, text mining | PubMed |
| Targeting Biliary Tract Cancers with Antibody-Drug Conjugates: Advances in Molecular Targets and Rational Combinations. | Cancers (Basel) | 2026 | 41749852 | PubTator, text mining | PubMed |
| In-depth source characterization and analytical control strategy for the charge variants of antibody drug conjugates: Case study and discussion. | J Pharm Biomed Anal | 2026 | 41747487 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/113451/papers?page=5